- 86.1k views
Improving outcomes in IBD with early effective therapy & biosimilars
Improving outcomes in Inflammatory Bowel Disease (IBD) involves early and effective therapy to reduce inflammation and prevent complications. Utilizing biosimilars, which are cost-effective alternatives to biologic medications, can enhance treatment accessibility and adherence. Early intervention with these therapies can lead to better disease control and improved quality of life for patients. Regular monitoring and personalized treatment plans are essential to maximize the benefits of early therapy and biosimilars. Ongoing research and clinical trials continue to support the efficacy and safety of biosimilars in managing IBD.
About the Speaker

Dr. Salem Awadh
Consultant Gastroenterologist, Amrita Medical Center, Abu Dhabi
Dr. Salim Awad is a consultant gastroenterologist who has completed extensive training in Gastroenterology from India, Newcastle, Belgium, and France. He has worked in several prestigious hospitals, including Royal Victoria Infirmary in Newcastle, Al Jazira & Central Hospitals in the UAE, and Freeman Hospital. Dr. Salim has long experience in endoscopy management and liver disease with follow up for the patients with liver transplant. Dr. Awad provides teaching programs for undergraduates and junior doctors at Al Ain University and has attended prominent conferences such as the World Congress of Gastroenterology in Sydney, the Digestive Disease Conference in Amsterdam, and the New Advances in Gastroenterology Conference in Berlin.
Upcoming Case Discussions
Gynaecologist’s Guide to Ovarian Cancer
Join us for a special webinar on World Ovarian Cancer Day, titled "Gynaecologist’s Guide to Ovarian Cancer." This expert-led session will delve into the latest advancements in early diagnosis, risk stratification, and evidence-based management of ovarian cancer. Tailored for gynecologists and healthcare professionals, the session will also explore real-world case discussions and multidisciplinary treatment approaches. Let’s come together to raise awareness and empower clinicians in the fight against this silent but deadly disease
Massive Transfusion Protocol
Massive Transfusion Protocol (MTP) is a standardized medical procedure activated in cases of severe hemorrhage, typically involving the rapid administration of large volumes of blood products. The goal is to restore circulating volume, maintain hemostasis, and prevent the lethal triad of hypothermia, acidosis, and coagulopathy. MTP usually involves a balanced ratio of packed red blood cells, plasma, and platelets, often in a 1:1:1 ratio. Early activation and coordination among trauma teams, laboratory services, and blood banks are essential for its success.
Sleep Apnea and Daytime Fatigue
Sleep Disorder Breathing is a term for a group of conditions with abnormal breathing patterns during sleep. This affects everyday functioning and well being.There are few types of SDB which include upper airways resistance, hypopnea, apnea, catathrenia and heavy snoring. People suffering with SDB can have daytime symptoms that result in poor sleep also. There can also be sleepiness, depressed mood, irritability and cognitive dysfunction.